Clinical Trial Update: A Study of 2141-V11 in Combination With Standard Treatments in People With Prostate Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating 2141-V11 in combination with standard treatments for prostate cancer; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• 2141-V11

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Prostate Cancer | Phase 2 | Status: RECRUITING